Form 4: Encompass Health Exec Sells Shares

Encompass Health Corp. EVP & CFO Douglas E. Coltharp reported transactions involving company stock, including the acquisition of shares via options and subsequent sales.

Summary

• Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp. (EHC), reported a series of transactions on May 15, 2026.
• Coltharp acquired 27,694 shares of Encompass Health Common Stock at a price of $32.94 per share, which appears to be related to the exercise of a non-qualified stock option.
• Following this acquisition, Coltharp sold 27,693 shares at a weighted average price of $106.83, with individual sales ranging from $106.28 to $107.22.
• An additional sale of 1 share was reported at $107.28.
• After these transactions, Coltharp beneficially owns 69,378 shares directly.
• Indirect beneficial ownership includes 27,480 shares held by an irrevocable trust, 125,631 shares held by an irrevocable trust for the benefit of children, and 37,749 shares held by his spouse.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to the significant sale of shares by a key executive, despite the profitable nature of the option exercise. The lack of disclosed reason for the sale adds to the ambiguity.

Positives

• The exercise of stock options at a price significantly lower than the sale price ($32.94 acquisition vs. $106.83 average sale price) indicates a profitable transaction for the executive.
• The executive still holds a substantial number of shares indirectly, suggesting continued investment in the company.

Negatives

• A significant number of shares were sold by a key executive, which could be interpreted negatively by the market, although the filing does not provide a reason for the sale.
• The sale of shares by the CFO might raise questions about the executive's confidence in the company's future performance, despite the profitable nature of the option exercise.

Risks

• The filing does not explicitly mention any risks. However, the sale of a large number of shares by a high-ranking executive could be perceived as a negative signal by investors, potentially impacting share price.
• The weighted average sale price indicates multiple transactions, and the undertaking to provide full information upon request suggests a need for detailed tracking of these sales.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While the exercise and sale of stock options by executives are common, the scale of this transaction by a CFO warrants attention from investors monitoring insider activity within the healthcare services sector.

Stakeholder Impact

• Shareholders: May interpret the sale of shares by the CFO as a potential negative signal, although the profitable exercise of options is a positive aspect.
• Employees: May be influenced by executive trading activity, potentially affecting morale or investment decisions.
• Creditors: Unlikely to be directly impacted by this specific transaction.

Next Steps

• The reporting person may be required to provide further details on the share sales upon request from the SEC, security holders, or the company.
• Investors will likely monitor future filings for any additional transactions by Mr. Coltharp or other executives.

Key Dates

Recommendation

The filing reports an insider transaction where a key executive exercised stock options and sold a significant number of shares. While the transaction was profitable for the executive, the sale of a large block of shares by the CFO without a stated reason can be a point of concern for investors. However, the executive still holds a substantial indirect beneficial ownership, suggesting continued commitment. Without further context on the reasons for the sale or broader company performance indicators, a 'hold' recommendation is prudent, advising investors to monitor future filings and company news.

Keywords

Encompass Health Corp, EHC, Form 4, Insider Trading, Stock Options, Share Sale, Beneficial Ownership, Douglas E. Coltharp, CFO, SEC Filing